Low prevalence of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from a tertiary burn care center in Tehran by Lari, A.R. et al.
International Journal of 
Immunopathology and Pharmacology
2015, Vol. 28(3) 384 –389
© The Author(s) 2015
Reprints and permissions: 
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/0394632015578343
iji.sagepub.com
Introduction
Pseudomonas aeruginosa is an obligate aerobic, 
gram-negative opportunist pathogen, which is able 
to grow and survive in hospital environment. This 
bacterium also plays an important role in a lot of 
severe infections, especially in immunocompro-
mised and burn patients admitted to the burns ward 
and contains acquired and intrinsic antibiotic 
resistant genes.1–3 P. aeruginosa is the second lead-
ing cause of nosocomial infections in hospitalized 
burn patients. P. aeruginosa is a highly adaptable 
micro-organism that can rapidly develop resistance 
to different types of broad-spectrum antibiotics. It 
can grow in hospital environments characterized 
by heavy antimicrobial use, and consequently it 
can be transmitted rapidly among hospitalized burn 
patients.1–3
Carbapenems are often used as a final choice for 
antibiotic therapy in treating infectious diseases 
associated with extended spectrum beta-lactamase 
(ESBL) producing gram-negative bacteria such 
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Production of metallo-beta-lactamase (MBL) is one of the main mechanisms for resistance in carbapenem antibiotics. 
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None of the isolates were positive for BlaNDM-1 and blaSPM-1. The results of this study showed that the prevalence of MBL 
is low in imipenem resistance P. aeruginosa and that other mechanisms could be involved in resistance to imipenem in 
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P. aeruginosa and Acinetobacter baumannii.4,5 The 
carbapenemases have been organized based on 
amino acid homology in the Ambler molecular clas-
sification system. Class A, C, and D beta-lactamases 
all share a serine residue in the active site, while 
Class B enzymes require the presence of zinc for 
activity (and hence are referred to as metallo-beta-
lactamases). Classes A, B, and D are of greatest 
clinical importance among nosocomial pathogens. 
The main mechanism of resistance in carbapenems 
is the production of carbapenemase by gram- 
negative bacteria.4,6 Metallo-beta-lactamase (MBL) 
is a class B beta-lactamase, which can hydrolyze 
carbapenem and other beta-lactams apart from 
Monobactam.4,6,7
The first isolate of MBL producer P. aeruginosa 
was reported in Japan in 1991 and since it has been 
reported worldwide.8 The most common MBLs are 
IMP-type carbapenemase (IMP) and Verona inte-
gron-encoded metallo-β-lactamase (VIM) types.9 
The blaVIM and blaIMP genes can spread from 
one Pseudomonas to another as well as Enter-
obacteriacea, since they are inserted into a plasmid-
born integron class 1 or 3.9 Various phenotypic 
methods for detection of MBL-producer isolates 
have been suggested such as using chelating agents 
(i.e. Ethylenediaminetetraacetic acid [EDTA]) and 
some MBL inhibitor like dipicokinic acid,10–16), 
nevertheless the specificity and sensitivity of these 
methods can be variable.11
DDST with imipenem-EDTA and CDT using 
imipenem and dipicolinic acid as MBL inhibitors 
are two of the most common methods utilized in 
various studies.10–12 The aim of this study was 
molecular and phonotypical detection of MBL in P. 
aeruginosa strains isolated from burn patients.
Materials and methods
Bacterial specimen
In this study, 255 P. aeruginosa were isolated from 
burn patients (with at least 1 week of hospitaliza-
tion) in Motahari Hospital (a referral burns center), 
Tehran, Iran from June to December 2013. Bacteria 
were collected from wound infections of hospital-
ized burn patients. Specimens were collected from 
male and female wards in hospital. The samples 
were collected by swabbing burn wound exudates, 
and immediately transported in transport culture 
media under standard conditions to the central lab-
oratory of the Antimicrobial Resistance Research 
Center. P. aeruginosa ATTCC27853 was used as 
the negative control. Isolated bacteria species were 
identified by specific biochemical and microbio-
logical tests such as oxidase, TSI, and glatinase. 
Polymerase chain reaction (PCR) was used as a 
confirmatory test for identification of P. aerugi-
nosa strains using specific primers for oprI for 
genus and oprL for the species. P. aeruginosa 
ATCC 27853 and Acinetobacter baumannii ATCC 
19606 were used as positive and negative control, 
respectively.
Antibiotic susceptibility testing
The antibiotic susceptibility testing was performed 
by disc diffusion method on Mueller–Hinton agar 
using cefotaxime (30 µg), ceftazidime (30 µg), 
aztreonam (30 µg), imipenem (10 µg), ticarcillin 
(75 µg), ticarcillin-clavulanic acid (75/10 µg), 
piperacillin (100 µg), piperacillin-Tazobactam 
(100/10 µg), ciprofloxacin (5 µg), gentamicin (10 µg), 
tobramycin (10 µg), kanamycin (30 µg), amikacin 
(30 µg), colistin (10 µg), tetracycline (30 µg), and 
trimethoprim (5 µg) according to clinical and labo-
ratory standards institute (CLSI) 2011. Standard 
antibiotics discs used in this study were purchased 
from MAST Company (Mast Diagnostics, UK).
Phenotypic detection of metallo-beta-lactamase
Double-disc synergy test. At first, 0.5 M of EDTA was pre-
pared by dissolving 186.1 g in 1 L of distilled water and 
pH 8 adjusted by NaOH. Then EDTA 750 µg/disc was pre-
pared. Also, the inhibition zone of that was measured 
alone. In the next step, the DDST was conducted by imi-
penem (10 µg) and EDTA distinctly, which was placed 
with a distance of 20 mm center-to-center with imipenem 
(10 µg). The strain with increasing size in the imipenem 
(10 µg) inhibition zone towards EDTA is considered a 
MBL producer in DDST.11–14
Combination disc test
In the CDT, imipenem alone and imipenem (10 µg) 
impregnated with dipicolinic acid (1000 µg/disc) 
were examined. The strains with an increase of ⩾5 
mm in the inhibition zone around the imipenem 
(10 µg) plus dipicolinic acid against imipenem (10 
µg) alone were considered a MBL producer.10,16
PCR for detection of MBL genes
All strains were examined for detection of blaVIM, 
blaIMP. New Delhi metallo-beta-lactamase-1 
(balNDM-1) and Sao Paulo metallo-beta-lactamase-1 
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(balSPM-1) by PCR with primers and PCR program 
were shown in Table 1.
PCR was performed for each sample with the 
following compounds: 1× concentration Specific 
PCR buffer, 0.4 mM of dNTPs mix, 0.7 mM of 
MgCl2, 1.6 M of each primer, one unit of Taq poly-
merase enzyme, 2 µL of DNA, and sterile distilled 
water to get 25 µL as a final volume. Finally, the 
PCR products were evaluated on a 1.5% agarose 
gel.
PCR (blaVIM, blaIMP genes) was performed in 
the following condition. The DNA thermocycle 
was programmed as follows: the first denatura-
tion at 94°C for 5 and 10 min for VIM and IMP, 
respectively; 30 cycles of 94°C for 60 and 40 se 
for VIM and IMP, respectively; annealing at 55°C 
for 60 and 40 s VIM and IMP, respectively; exten-
sion at 72°C for 60 s; and at last the final exten-
sion at 72°C for 5 and 7 min for VIM and IMP, 
respectively.
Internal positive controls were considered in 
this study. The first positive strain is sequenced 
and used for positive control in all tested strains.
Multiplex PCR (balNDM-1 and balSPM-1 genes) 
was performed in the following condition. The 
DNA thermocycle was programmed as follows: 
the first denaturation at 94°C for 60 s for set; 30 
cycles of 94°C for 30 s; annealing at 55°C for 60 s; 
extension at 72°C for 60 s; and at last the final 
extension at 72°C for 60 s.
Results
Two hundred and fifty-five strains were confirmed as 
P. aeruginosa by specific biochemical tests and 
subsequently by PCR. The results were interpreted 
according to CLSI 2011 AST guidelines. All tested 
strains were resistant to imipenem. The antibiotic 
resistant patterns were shown in Table 2.
AK: amikacin; AT, aztreonam; CAZ: ceftazi-
dime; CEF: cefepime; CI: ciprofloxacin; CTX: 
cefotaxime, GM: gentamicin, IMI : imipenem; K: 
kanamycin; PRL: piperacillin-Tazobactam; PTZ: 
piperacillin; T: tetracycline; TC: ticarcillin; TC-c: 
ticarcillin-clavulanic acid; TM: trimethoprim, TO: 
tobramycin.
Table 1. Primer sequences and their amplicon sizes for metallo-beta-lactamase genes.
Genes Sequence (5’→3’) Amplicon size (pb) Reference
oprl-F1 ATGAACAACGTTCTGAAATTCTCTGCT 249 14
oprl-R1 CTTGCGGCTGGCTTTTTCCAG  
oprL-F1 ATGGAAATGCTGAAATTCGGC 504  
oprL-R1 CTTCTTCAGCTCGACGCGACG  
blaVIM–F ATGTTAAAAGTTATTAGTAGT 801 15
blaVIM -R CTACTCGGCGACTGAGCGAT  
BlaIMP-F GATGGTGTTTGGTCGCATA 139 16
BlaIMP-R CGAATGCGCAGCACCAG  
blaNDM-1-F CCCGGCCACACCAGTGACA 129  
blaNDM-1-R GTAGTGCTCAGTGTCGGCAT 17
blaSPM-1-F GGGTGGCTAAGACTATGAAGCC 447  
blaSPM-1-R GCCGCCGAGCTGAATCGG  
Table 2. Antibiotic resistance patterns of P. aeruginosa isolates.
Patterns Antibiotic resistance patterns n (%)
1 CTX CAZ AT CEF IMI PTZ PYR TC TC-C GM AK TO K TM CI 112 (49.9)
2 CTX CAZ AT CEF IMI PTZ PYR TC TC-C GM AK TO K TM CI T 92 (41)
3 CTX CAZ AT CEF IMI PYR TC TC-C GM AK TO K TM T 3 (1.3)
4 CTX AT CEF IMI PTZ PYR TC-C AK K TM CI T 3 (1.3)
5 CTX IMI PTZ PYR TC TC-C GM AK TO K TM CI 3 (1.3)
6 CTX IMI PYR TC TC-C AK TO K TM CI 3 (1.3)
7 CTX CAZ CEF IMI TC TC-C GM AK TO K TM CI 3 (1.3)
8 CTX CAZ AT CEF IMI TC TC-C GM AK TO K TM CI 3 (1.3)
9 CTX AT CEF IMI PTZ PYR TC TC-C GM AK TO K TM CI T 3 (1.3)
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Antibiotic resistance pattern 1 (resistant to all 
tested antibiotics except colistin) was the most 
observed patterns in both two studied wards.
The first five antibiotics prescribed that were 
consided as a first line of treatment were: cefepime, 
ciprofloxacin, amikacin, meropenem, imipenem, 
piperacillin-Tazobactam, and gentamicin. In total, 
161 (63%) of imipenem-resistant strains were 
shown increasing the diameter of the inhibition 
zone by at least 5 mm with imipenem-dipicolinic 
acid compared with imipenem alone in CDT. 
Simultaneously, dipicolinic acid alone increased 
the inhibition zone to 12 mm (Figure 1).
None of them maintained synergistic effects 
between EDTA alone and imipenem alone. Direct 
sequencing of PCR amplified products was 
carried out using ABI 3730X capillary sequencer 
(Genfanavaran, Macrogen, Seoul, Republic of 
Korea). Sequence analysis showed that blaVIM and 
blaIMP genes were detected in five and four tested 
strains, respectively (Figures 2 and 3).
All of these nine strains which were confirmed 
by PCR as MBL producers, had positive results in 
CDT. None of the CDT negative strains had MBL 
genes, but 152 out of 161 which were CDT posi-
tive have not shown the specific band for MBL-
tested genes after PCR and gel electrophoresis. 
blaNDM-1and blaSPM-1 have been not detected.
Discussion
Prevalence of carbapenem resistance P. aeruginosa is 
increasing mainly due to potential MBL production, 
which ultimately can cause high morbidity and mor-
tality, particularly among hospitalized burn patients.21 
The results of the study in 2014 in Colombia indi-
cated that 60% of carbapenem resistant P. aeruginosa 
was a VIM producer and none of them was positive 
for IMP and NDM.22 In this study, as in our results, 
NDM-producer P. aeruginosa has been not detected, 
but the prevalence of VIM is higher than in our study. 
On the other hand, IMP has shown less prevalence in 
comparison to our results. Overall 60% of imipenem 
resistant P. aeruginosa in Colombia has been con-
firmed as a MBL producer, but 3.5% of imipenem 
resistant P. aeruginosa in the our study were MBL 
producers. This differentiation of MBL prevalence 
can relate to a kind of antibiotic therapy in two differ-
ent countries and may be associated with a specific 
mechanism which is prevalent in various countries. It 
can be considered that in 2010 in Iran 23% of non-
susceptible imipenem P. aeruginosa had blaVIM and 
blaIMP genes23 and this prevalence higher compared 
to our tested isolates in 2013. These different results 
in two different time frames but in the same country 
can indicate the change of carbapenem resistant 
Figure 1. The inhibition zone of dipicolinic acid disc alone.
11 10 9       8        7        6       5        4        3        2        1         M 
801bp
Figure 2. PCR amplification fragments for detection of vim 
gene among P. aeroginosa isolates. Lanes 1–5: negative VIM1; 
lane 6: Negative control for VIM1 gene; lanes 7–10: positive 
VIM1 strains; lane 11: positive control; M: 1 kb marker.
M                 1                      2                3                     4
139bp
Figure 3. PCR amplification fragments for detection of imp 
gene among P. aeroginosa isolates Lane 1: negative control; lane 
2: positive control for imp gene; lanes 3 and 4: positive imp 
strains; M: 1 kb marker.
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mechanism in P. aeruginosa and could be related to 
the existence of another resistant mechanism.
DDST methods with imipenem and EDTA and 
CDT with imipenem and dipicolinic acid are used 
as two ordinary phenotypic methods for detection 
of MBLs.11 In a previous study in Iran, the DDST 
test was used for the detection of MBL in 
Pseudomonas spp., which showed that 23% of 
non-susceptible imipenem isolates have blaVIM 
and blaIMP genes.23 In 2011 in Norway, the sensi-
tivity and specificity of CDT with dipicolinic acid 
were 100% in K. pneumoniae strains.10
In 2013 in Iran, 87.8% of tested imipenem 
resistant isolates were confirmed to be MBL pro-
ducer based on DDST. blaIMP and blaVIM were 
detected in 24.4% and 56% of strains, respec-
tively. This differention in the results of this 
study and the current study can be associated 
with the location of sampling in patients. On the 
other hand, these two studies were conducted in 
two different hospitals in two different cities with 
different antibiotic therapy policies.24
It can be noted that one antibiotic-resistant pattern 
was the most observed pattern in the two studied 
wards and it can indicate the spread of one bacterial 
clone in the two wards.
In the present study, no synergistic effect was 
observed using the DDST techniques, but the CD 
test was positive in 63% of imipenem resistant P. 
aeruginosa. Our findings also showed that dipico-
linic acid alone tested for Pseudomonas strains had 
an inhibition zone up to 12 mm. Thus, an increase 
of 5 mm in the inhibition zone around imipenem 
with dipicolinic acid against imipenem alone can-
not explain the synergistic effect of these two mate-
rials. In this regard, the specificity of dipicolinic 
acid was 81% for the detection of MBL in study of 
Pasteran et al.16
On the other hand, molecular tests for the pres-
ence of genes blNDM and blaSPM were negative and 
only 3.5% of isolates had blaVIM and blaIMP genes. 
It can explain the other carbapenem resistant 
mechanisms among P. aeruginosa like the efflux 
pump25 and over-expression of AmpC combined 
with porin loss.
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